Pharma & Healthcare

Global Repurposed Drugs Market Insights, Forecast to 2030

Drug repurposing (also called drug repositioning, reprofiling or re-tasking) is a strategy for identifying new uses for approved or investigational drugs that are outside the scope of the original medical indication. This strategy offers various advantages over developing an entirely new drug for a given indication.
Market Analysis and Insights: Global Repurposed Drugs Market
The global Repurposed Drugs market is projected to grow from US$ 16880 million in 2024 to US$ 27320 million by 2030, at a Compound Annual Growth Rate (CAGR) of 8.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Repurposed Drugs market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Repurposed Drugs, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Repurposed Drugs, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Repurposed Drugs revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Repurposed Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Repurposed Drugs revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Segment by Type
Generic Drugs
Clinical Trial Failed Drugs
Segment by Application
Cardiovascular Diseases
Mental Illness
Cancer
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Repurposed Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Repurposed Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Repurposed Drugs revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Repurposed Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Generic Drugs
1.2.3 Clinical Trial Failed Drugs
1.3 Market by Application
1.3.1 Global Repurposed Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Diseases
1.3.3 Mental Illness
1.3.4 Cancer
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Repurposed Drugs Market Perspective (2019-2030)
2.2 Global Repurposed Drugs Growth Trends by Region
2.2.1 Repurposed Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Repurposed Drugs Historic Market Size by Region (2019-2024)
2.2.3 Repurposed Drugs Forecasted Market Size by Region (2025-2030)
2.3 Repurposed Drugs Market Dynamics
2.3.1 Repurposed Drugs Industry Trends
2.3.2 Repurposed Drugs Market Drivers
2.3.3 Repurposed Drugs Market Challenges
2.3.4 Repurposed Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Repurposed Drugs by Players
3.1.1 Global Repurposed Drugs Revenue by Players (2019-2024)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Repurposed Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Repurposed Drugs, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Repurposed Drugs Market Concentration Ratio
3.4.1 Global Repurposed Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Repurposed Drugs Revenue in 2023
3.5 Global Key Players of Repurposed Drugs Head office and Area Served
3.6 Global Key Players of Repurposed Drugs, Product and Application
3.7 Global Key Players of Repurposed Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Repurposed Drugs Breakdown Data by Type
4.1 Global Repurposed Drugs Historic Market Size by Type (2019-2024)
4.2 Global Repurposed Drugs Forecasted Market Size by Type (2025-2030)
5 Repurposed Drugs Breakdown Data by Application
5.1 Global Repurposed Drugs Historic Market Size by Application (2019-2024)
5.2 Global Repurposed Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Repurposed Drugs Market Size (2019-2030)
6.2 North America Repurposed Drugs Market Size by Type
6.2.1 North America Repurposed Drugs Market Size by Type (2019-2024)
6.2.2 North America Repurposed Drugs Market Size by Type (2025-2030)
6.2.3 North America Repurposed Drugs Market Share by Type (2019-2030)
6.3 North America Repurposed Drugs Market Size by Application
6.3.1 North America Repurposed Drugs Market Size by Application (2019-2024)
6.3.2 North America Repurposed Drugs Market Size by Application (2025-2030)
6.3.3 North America Repurposed Drugs Market Share by Application (2019-2030)
6.4 North America Repurposed Drugs Market Size by Country
6.4.1 North America Repurposed Drugs Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Repurposed Drugs Market Size by Country (2019-2024)
6.4.3 North America Repurposed Drugs Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Repurposed Drugs Market Size (2019-2030)
7.2 Europe Repurposed Drugs Market Size by Type
7.2.1 Europe Repurposed Drugs Market Size by Type (2019-2024)
7.2.2 Europe Repurposed Drugs Market Size by Type (2025-2030)
7.2.3 Europe Repurposed Drugs Market Share by Type (2019-2030)
7.3 Europe Repurposed Drugs Market Size by Application
7.3.1 Europe Repurposed Drugs Market Size by Application (2019-2024)
7.3.2 Europe Repurposed Drugs Market Size by Application (2025-2030)
7.3.3 Europe Repurposed Drugs Market Share by Application (2019-2030)
7.4 Europe Repurposed Drugs Market Size by Country
7.4.1 Europe Repurposed Drugs Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Repurposed Drugs Market Size by Country (2019-2024)
7.4.3 Europe Repurposed Drugs Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Repurposed Drugs Market Size (2019-2030)
8.2 China Repurposed Drugs Market Size by Type
8.2.1 China Repurposed Drugs Market Size by Type (2019-2024)
8.2.2 China Repurposed Drugs Market Size by Type (2025-2030)
8.2.3 China Repurposed Drugs Market Share by Type (2019-2030)
8.3 China Repurposed Drugs Market Size by Application
8.3.1 China Repurposed Drugs Market Size by Application (2019-2024)
8.3.2 China Repurposed Drugs Market Size by Application (2025-2030)
8.3.3 China Repurposed Drugs Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Repurposed Drugs Market Size (2019-2030)
9.2 Asia Repurposed Drugs Market Size by Type
9.2.1 Asia Repurposed Drugs Market Size by Type (2019-2024)
9.2.2 Asia Repurposed Drugs Market Size by Type (2025-2030)
9.2.3 Asia Repurposed Drugs Market Share by Type (2019-2030)
9.3 Asia Repurposed Drugs Market Size by Application
9.3.1 Asia Repurposed Drugs Market Size by Application (2019-2024)
9.3.2 Asia Repurposed Drugs Market Size by Application (2025-2030)
9.3.3 Asia Repurposed Drugs Market Share by Application (2019-2030)
9.4 Asia Repurposed Drugs Market Size by Region
9.4.1 Asia Repurposed Drugs Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Repurposed Drugs Market Size by Region (2019-2024)
9.4.3 Asia Repurposed Drugs Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Repurposed Drugs Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Repurposed Drugs Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Repurposed Drugs Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva
11.1.1 Teva Company Details
11.1.2 Teva Business Overview
11.1.3 Teva Repurposed Drugs Introduction
11.1.4 Teva Revenue in Repurposed Drugs Business (2019-2024)
11.1.5 Teva Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Repurposed Drugs Introduction
11.2.4 Novartis Revenue in Repurposed Drugs Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Repurposed Drugs Introduction
11.3.4 Mylan Revenue in Repurposed Drugs Business (2019-2024)
11.3.5 Mylan Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Repurposed Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Repurposed Drugs Business (2019-2024)
11.4.5 Johnson & Johnson Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Repurposed Drugs Introduction
11.5.4 Pfizer Revenue in Repurposed Drugs Business (2019-2024)
11.5.5 Pfizer Recent Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Details
11.6.2 Bausch Health Business Overview
11.6.3 Bausch Health Repurposed Drugs Introduction
11.6.4 Bausch Health Revenue in Repurposed Drugs Business (2019-2024)
11.6.5 Bausch Health Recent Developments
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Repurposed Drugs Introduction
11.7.4 GSK Revenue in Repurposed Drugs Business (2019-2024)
11.7.5 GSK Recent Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Details
11.8.2 ChemRar Group Business Overview
11.8.3 ChemRar Group Repurposed Drugs Introduction
11.8.4 ChemRar Group Revenue in Repurposed Drugs Business (2019-2024)
11.8.5 ChemRar Group Recent Developments
11.9 Glenmark
11.9.1 Glenmark Company Details
11.9.2 Glenmark Business Overview
11.9.3 Glenmark Repurposed Drugs Introduction
11.9.4 Glenmark Revenue in Repurposed Drugs Business (2019-2024)
11.9.5 Glenmark Recent Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Details
11.10.2 Fujifilm Business Overview
11.10.3 Fujifilm Repurposed Drugs Introduction
11.10.4 Fujifilm Revenue in Repurposed Drugs Business (2019-2024)
11.10.5 Fujifilm Recent Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Details
11.11.2 Dr. Reddy Business Overview
11.11.3 Dr. Reddy Repurposed Drugs Introduction
11.11.4 Dr. Reddy Revenue in Repurposed Drugs Business (2019-2024)
11.11.5 Dr. Reddy Recent Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Details
11.12.2 R-Pharma Business Overview
11.12.3 R-Pharma Repurposed Drugs Introduction
11.12.4 R-Pharma Revenue in Repurposed Drugs Business (2019-2024)
11.12.5 R-Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Repurposed Drugs Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of Generic Drugs
Table 3. Key Players of Clinical Trial Failed Drugs
Table 4. Global Repurposed Drugs Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Repurposed Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Repurposed Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Repurposed Drugs Market Share by Region (2019-2024)
Table 8. Global Repurposed Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Repurposed Drugs Market Share by Region (2025-2030)
Table 10. Repurposed Drugs Market Trends
Table 11. Repurposed Drugs Market Drivers
Table 12. Repurposed Drugs Market Challenges
Table 13. Repurposed Drugs Market Restraints
Table 14. Global Repurposed Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Repurposed Drugs Revenue Share by Players (2019-2024)
Table 16. Global Top Repurposed Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2023)
Table 17. Global Repurposed Drugs Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Repurposed Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Repurposed Drugs, Headquarters and Area Served
Table 20. Global Key Players of Repurposed Drugs, Product and Application
Table 21. Global Key Players of Repurposed Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Repurposed Drugs Revenue Market Share by Type (2019-2024)
Table 25. Global Repurposed Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Repurposed Drugs Revenue Market Share by Type (2025-2030)
Table 27. Global Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Repurposed Drugs Revenue Share by Application (2019-2024)
Table 29. Global Repurposed Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Repurposed Drugs Revenue Share by Application (2025-2030)
Table 31. North America Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Repurposed Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Repurposed Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Repurposed Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Repurposed Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Repurposed Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Repurposed Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Repurposed Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Repurposed Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Repurposed Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Repurposed Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Repurposed Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Repurposed Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Repurposed Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Repurposed Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Repurposed Drugs Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Repurposed Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Repurposed Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Repurposed Drugs Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Repurposed Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 63. Teva Company Details
Table 64. Teva Business Overview
Table 65. Teva Repurposed Drugs Product
Table 66. Teva Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 67. Teva Recent Developments
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Repurposed Drugs Product
Table 71. Novartis Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 72. Novartis Recent Developments
Table 73. Mylan Company Details
Table 74. Mylan Business Overview
Table 75. Mylan Repurposed Drugs Product
Table 76. Mylan Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 77. Mylan Recent Developments
Table 78. Johnson & Johnson Company Details
Table 79. Johnson & Johnson Business Overview
Table 80. Johnson & Johnson Repurposed Drugs Product
Table 81. Johnson & Johnson Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 82. Johnson & Johnson Recent Developments
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Repurposed Drugs Product
Table 86. Pfizer Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 87. Pfizer Recent Developments
Table 88. Bausch Health Company Details
Table 89. Bausch Health Business Overview
Table 90. Bausch Health Repurposed Drugs Product
Table 91. Bausch Health Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 92. Bausch Health Recent Developments
Table 93. GSK Company Details
Table 94. GSK Business Overview
Table 95. GSK Repurposed Drugs Product
Table 96. GSK Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 97. GSK Recent Developments
Table 98. ChemRar Group Company Details
Table 99. ChemRar Group Business Overview
Table 100. ChemRar Group Repurposed Drugs Product
Table 101. ChemRar Group Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 102. ChemRar Group Recent Developments
Table 103. Glenmark Company Details
Table 104. Glenmark Business Overview
Table 105. Glenmark Repurposed Drugs Product
Table 106. Glenmark Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 107. Glenmark Recent Developments
Table 108. Fujifilm Company Details
Table 109. Fujifilm Business Overview
Table 110. Fujifilm Repurposed Drugs Product
Table 111. Fujifilm Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 112. Fujifilm Recent Developments
Table 113. Dr. Reddy Company Details
Table 114. Dr. Reddy Business Overview
Table 115. Dr. Reddy Repurposed Drugs Product
Table 116. Dr. Reddy Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 117. Dr. Reddy Recent Developments
Table 118. R-Pharma Company Details
Table 119. R-Pharma Business Overview
Table 120. R-Pharma Repurposed Drugs Product
Table 121. R-Pharma Revenue in Repurposed Drugs Business (2019-2024) & (US$ Million)
Table 122. R-Pharma Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Repurposed Drugs Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Repurposed Drugs Market Share by Type: 2023 VS 2030
Figure 3. Generic Drugs Features
Figure 4. Clinical Trial Failed Drugs Features
Figure 5. Global Repurposed Drugs Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Repurposed Drugs Market Share by Application: 2023 VS 2030
Figure 7. Cardiovascular Diseases Case Studies
Figure 8. Mental Illness Case Studies
Figure 9. Cancer Case Studies
Figure 10. Other Case Studies
Figure 11. Repurposed Drugs Report Years Considered
Figure 12. Global Repurposed Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Repurposed Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Repurposed Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Repurposed Drugs Market Share by Players in 2023
Figure 16. Global Top Repurposed Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Repurposed Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Repurposed Drugs Revenue in 2023
Figure 18. North America Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Repurposed Drugs Market Share by Type (2019-2030)
Figure 20. North America Repurposed Drugs Market Share by Application (2019-2030)
Figure 21. North America Repurposed Drugs Market Share by Country (2019-2030)
Figure 22. United States Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Repurposed Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 25. Europe Repurposed Drugs Market Share by Type (2019-2030)
Figure 26. Europe Repurposed Drugs Market Share by Application (2019-2030)
Figure 27. Europe Repurposed Drugs Market Share by Country (2019-2030)
Figure 28. Germany Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. China Repurposed Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 35. China Repurposed Drugs Market Share by Type (2019-2030)
Figure 36. China Repurposed Drugs Market Share by Application (2019-2030)
Figure 37. Asia Repurposed Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 38. Asia Repurposed Drugs Market Share by Type (2019-2030)
Figure 39. Asia Repurposed Drugs Market Share by Application (2019-2030)
Figure 40. Asia Repurposed Drugs Market Share by Region (2019-2030)
Figure 41. Japan Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. South Korea Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Taiwan Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. India Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Australia Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Repurposed Drugs Market Size YoY (2019-2030) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Repurposed Drugs Market Share by Type (2019-2030)
Figure 49. Middle East, Africa, and Latin America Repurposed Drugs Market Share by Application (2019-2030)
Figure 50. Middle East, Africa, and Latin America Repurposed Drugs Market Share by Country (2019-2030)
Figure 51. Brazil Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Mexico Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Turkey Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Israel Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 56. GCC Countries Repurposed Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 57. Teva Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 58. Novartis Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 59. Mylan Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 61. Pfizer Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 62. Bausch Health Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 63. GSK Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 64. ChemRar Group Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 65. Glenmark Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 66. Fujifilm Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 67. Dr. Reddy Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 68. R-Pharma Revenue Growth Rate in Repurposed Drugs Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies